WHO Classification of Haematolymphoid Tumours
GPTKB entity
Statements (42)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:insurance
|
| gptkbp:class |
morphology
clinical features genetic features immunophenotype |
| gptkbp:developedBy |
gptkb:World_Health_Organization
|
| gptkbp:edition |
2016 edition
2008 edition 2001 edition 2022 edition |
| gptkbp:editor |
gptkb:Harald_Stein
gptkb:Jürgen_Thiele Elias Campo James W. Vardiman Nancy Lee Harris Saeed S. Jaffe Steven H. Swerdlow |
| gptkbp:firstPublished |
2001
|
| gptkbp:focusesOn |
haematolymphoid neoplasms
|
| https://www.w3.org/2000/01/rdf-schema#label |
WHO Classification of Haematolymphoid Tumours
|
| gptkbp:includes |
myelodysplastic syndromes
myeloproliferative neoplasms lymphomas plasma cell neoplasms histiocytic and dendritic cell neoplasms leukemias |
| gptkbp:language |
English
|
| gptkbp:latestReleaseVersion |
2022
5th edition |
| gptkbp:publishedIn |
WHO Blue Books series
|
| gptkbp:relatedTo |
gptkb:International_Classification_of_Diseases_for_Oncology
ICD-O |
| gptkbp:targetAudience |
medical researchers
oncologists pathologists hematologists |
| gptkbp:usedFor |
research
clinical management diagnosis of blood cancers |
| gptkbp:website |
https://whobluebooks.iarc.fr/
|
| gptkbp:bfsParent |
gptkb:WHO_classification
|
| gptkbp:bfsLayer |
6
|